These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2465979)

  • 1. Anturan for secondary prophylaxis of myocardial infarction.
    Bokarev IN; Lusov VA; Golikov AP; Ptushkin VV; Zvereva TV; Savenkov MP; Seregina MV
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):595-8. PubMed ID: 2465979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary prevention of myocardial infarction.
    Davies JA
    Int J Clin Pharmacol Res; 1985; 5(5):303-7. PubMed ID: 3905632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infarction prophylaxis--prevention of the sudden heart death? An alternative].
    Gross F
    MMW Munch Med Wochenschr; 1982 May; 124(18):435-6. PubMed ID: 6124885
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sulfinpyrazone (Anturan) after myocardial infarction].
    Faergeman O
    Ugeskr Laeger; 1980 Sep; 142(39):2571-2. PubMed ID: 7445168
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulphinpyrazone (Anturan) after myocardial infarct.
    Watt M
    N Z Med J; 1979 Oct; 90(646):352. PubMed ID: 392352
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of ischemic cardiopathy, with special reference to secondary prevention in the post-infarct period].
    Greco R; Siciliano S; Gentile F; Elia L; Murena E; Forni N; Boccalatte A; Marsico F
    Boll Soc Ital Cardiol; 1981; 26(8):759-65. PubMed ID: 6127093
    [No Abstract]   [Full Text] [Related]  

  • 7. [The Anturan reinfarct study].
    Sherry S
    Wien Med Wochenschr Suppl; 1980; 61():17-22. PubMed ID: 6930766
    [No Abstract]   [Full Text] [Related]  

  • 8. [Interaction of sulfinpyrazone (Anturan) and glibenclamide (Euglucon) in type II diabetic patients].
    Kritz H; Najemnik C; Irsigler K
    Wien Med Wochenschr; 1983 May; 133(9):237-43. PubMed ID: 6408808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPP) randomized trial. The Captopril Prevention Project (CAPP) Study Group.
    Curr Hypertens Rep; 1999 Dec; 1(6):466-7. PubMed ID: 11041675
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of anturan in patients with ischemic heart disease with a history of acute myocardial infarction].
    Bokarev IN; Golikov AP; Liusov VA; Ptushkin VV; Zvereva TV
    Klin Med (Mosk); 1987 Oct; 65(10):29-32. PubMed ID: 3431051
    [No Abstract]   [Full Text] [Related]  

  • 12. [Perspectives of the preventive treatment of patients after myocardial infarction].
    Chodorowski Z
    Pol Tyg Lek; 1984 Jan; 39(5):159-61. PubMed ID: 6146127
    [No Abstract]   [Full Text] [Related]  

  • 13. [New aspects in the prophylaxis of myocardial reinfarction (author's transl)].
    Hitzenberger G
    Aktuelle Gerontol; 1982 Jan; 12(1):7-11. PubMed ID: 6121504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.
    Goodman S; Hill C; Bata I; Fung A; Higginson L; Lam J; Massel D; McCans J; Nasmith J; Stanton E; Thompson C; Warnica W; Langer A
    Can J Cardiol; 1996 Nov; 12(11):1183-90. PubMed ID: 9191511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).
    Dunkelgrun M; Boersma E; Schouten O; Koopman-van Gemert AW; van Poorten F; Bax JJ; Thomson IR; Poldermans D;
    Ann Surg; 2009 Jun; 249(6):921-6. PubMed ID: 19474688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure: Part II.
    Wilkes MS; Middlekauff H; Hoffman JR
    West J Med; 1999 Jun; 170(6):339-42. PubMed ID: 10443162
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of recurrent myocardial infarct].
    Kallio V
    Duodecim; 1981; 97(5):227-30. PubMed ID: 6113128
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
    Arós F; Loma-Osorio A; Vila J; López-Bescós L; Cuñat J; Rodríguez E; San José JM; Heras M; Marrugat J;
    Rev Esp Cardiol; 2006 Apr; 59(4):313-20. PubMed ID: 16709383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure.
    Hognestad A; Dickstein K; Myhre E; Snapinn S; Kjekshus J;
    Am J Cardiol; 2004 Mar; 93(5):603-6. PubMed ID: 14996587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anturane reinfarction trial.
    Rothlin M
    N Engl J Med; 1980 Jul; 303(1):48. PubMed ID: 6103510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.